A phase 3, randomized, double-blind, placebo-controlled, multicenter study of pegylated recombinant human hyaluronidase (PEGPH20) in combination with nab-paclitaxel plus gemcitabine compared with placebo plus nab-paclitaxel and gemcitabine in subjects with hyaluronan-high stage IV previously untreated pancreatic ductal adenocarcinoma

UCI-15-94
NCT02715804
Cancer - Pancreas
Jason Zell
Open
Treatment
PEGPH20, Placebo
Chemotherapy multiple agents systemic
3
Adult
Local

For information about cancer clinical trials at the UCI Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.